Skip to content

Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis

Laparoendoscopic Rendez Vous (Intraoperative ERCP) vs Two Stage Approach (Preoperative ERCP Followed by Laparoscopic Cholecystectomy) for the Management of Cholelithiasis/Choledocholithiasis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00416234
Enrollment
300
Registered
2006-12-27
Start date
2006-09-30
Completion date
2010-12-31
Last updated
2010-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choledocholithiasis, Cholelithiasis

Brief summary

The purpose of the study is to assess whether combined intraoperative ERCP and CBD clearance with laparo-endoscopic rendez-vous during laparoscopic cholecystectomy (one stage approach) is or not superior to the standard practice of preoperative ERCP, sphincterotomy and CBD clearance followed by laparoscopic cholecystectomy (two stage approach) in patients with combined cholelithiasis and choledocholithiasis.

Detailed description

The ideal management of concomitant cholelithiasis and choledocholithiasis is not known yet. There are several options, including one-stage or two-stage approaches. The most commonly used practice is the two-stage management which consists of preoperative ERCP, sphincterotomy and CBD clearance followed by laparoscopic cholecystectomy. However, with this approach, a number of patients will be submitted to an unnecessary ERCP while some others will develop complications, mainly pancreatitis due to inadvertent pancreatic duct cannulation. Laparo-endoscopic rendez-vous methods have been described in order to obtain selective CBD cannulation and omit the risk of post-ERCP pancreatitis. In this procedure, during laparoscopic cholecystectomy, a wire is inserted through the cystic duct into the common bile duct, advanced into the duodenum where is found endoscopically, gripped with a snare and retrieved through the mouth. The a sphincterotome is inserted over the wire and elective CBD cannulation is obtained to be followed by sphincterotomy and CBD clearance intraoperatively. The method has been described by several authors in small to moderate case series, its safety has been proven and it appears that reduces both the length of hospital stay and the incidence of post-ERCP pancreatitis.However, it has not been popularized and has never been tested over the standard two-stage management. In our hospital, the standard approach for cholelithiasis and choledocholithiasis has been, as well, the two-stage (preop ERCP and sphincterotomy followed by laparoscopic cholecystectomy)approach. We initially assessed the feasibility and safety of the laparo-endoscopic rendez vous with a pilot study and now we intend to compare the two methods in a prospective randomized trial.

Interventions

PROCEDURELaparoendoscopic Rendez vous

intraoperative ERCP for CBD clearance during laparoscopic cholecystectomy

PROCEDUREpreoperative ERCP and CBD clearance

ERCP and CBD clearance followed by laparoscopic cholecystectomy

Sponsors

Larissa University Hospital
CollaboratorOTHER
University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients must be able to give informed consent preoperatively * ASA I-III * patients at high risk to have CBD stones (jaundice, cholangitis, grossly deranged LFTs, CBD stones found on US or MRCP)

Exclusion criteria

* patients not fit for surgery (ASA IV) * previous ERCP and sphincterotomy * previous upper abdominal surgery * pregnancy at time of surgery

Design outcomes

Primary

MeasureTime frame
postoperative hospital stayfrom onset of intervention to discharge

Secondary

MeasureTime frame
failure rate of selective CBD cannulationduring ERCP
incidence of multiple endoscopic procedureswithin 30 days
incidence of hyperamylasemiawithin 48 hours post-ERCP
success rate of CBD clearanceduring ERCP
total hospital stayfrom admission to discharge
complications other but pancreatitiswithin 30 days
deathwithin 30 days
incidence of severe pancreatitis (APACHE II score >6)within 48 hours post-ERCP

Countries

Greece

Contacts

Primary ContactGeorge Tzovaras, MD
gtzovaras@hotmail.com+30 2410 682730
Backup ContactIoannis Baloyiannis, MD
balioan@hotmail.com+30 2410 682728

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026